(Q43670704)

English

Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns

scientific article published on 26 February 2013

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Recurrences of hepatocellular carcinoma following complete remission by transarterial chemoembolization or radiofrequency therapy: Focused on the recurrence patterns (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

author name string

Wonhyeong Park

1

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Young-Hwa Chung

2

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Jeong A Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Young-Joo Jin

4

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Don Lee

5

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Ju Hyun Shim

6

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Danbi Lee

7

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kang Mo Kim

8

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Young-Suk Lim

9

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Han Chu Lee

10

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Yung Sang Lee

11

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Pyo Nyun Kim

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Kyu Bo Sung

13

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

publication date

26 February 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Hepatology Research

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

43

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

1304-1312

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

Global cancer statistics, 2002

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Estimating the world cancer burden: Globocan 2000.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Projecting future complications of chronic hepatitis C in the United States

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Loco-regional treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Postoperative recurrence of hepatocellular carcinoma. Two hundred five consecutive patients who underwent hepatic resection in 15 years.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Risk factors contributing to early and late phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Surgery and transplantation for hepatocellular cancer

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Management of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Design and endpoints of clinical trials in hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Computed tomography-guided transarterial chemoembolization as the initial therapy for hepatocellular carcinoma: experience of 75 cases in a single institute

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Recurrences of hepatocellular carcinoma following initial remission by transcatheter arterial chemoembolization.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

A randomized controlled trial of radiofrequency ablation with ethanol injection for small hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Randomised controlled trial comparing percutaneous radiofrequency thermal ablation, percutaneous ethanol injection, and percutaneous acetic acid injection to treat hepatocellular carcinoma of 3 cm or less

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Small hepatocellular carcinoma in cirrhosis: randomized comparison of radio-frequency thermal ablation versus percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Percutaneous radiofrequency ablation therapy for hepatocellular carcinoma: a proposed new grading system for the ablative margin and prediction of local tumor progression and its validation.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Radiofrequency ablation of hepatocellular carcinoma: correlation between local tumor progression after ablation and ablative margin

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Radiofrequency ablation of hepatocellular carcinoma: long-term experience with expandable needle electrodes.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Early-stage hepatocellular carcinoma in patients with cirrhosis: long-term results of percutaneous image-guided radiofrequency ablation.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Local therapeutic results of computed tomography-guided transcatheter arterial chemoembolization for hepatocellular carcinoma: results of 265 tumors in 79 patients.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: a prospective cohort study.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Therapeutic results of computed-tomography-guided transcatheter arterial chemoembolization for local recurrence of hepatocellular carcinoma after initial transcatheter arterial chemoembolization: the results of 85 recurrent tumors in 35 patients.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Analysis of recurrence pattern and its influence on survival outcome after radiofrequency ablation of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Recurrence-free survival after radiofrequency ablation of hepatocellular carcinoma. A registry report of the impact of risk factors on outcome.

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Systematic review and meta-analysis of survival and disease recurrence after radiofrequency ablation for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FHEPR.12083

21 January 2018

Identifiers

10.1111/HEPR.12083

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43670704&oldid=2102412376"